Drug Companies
Jason Momoa takes on Big Pharma with car chases and knife fights in a new action movie
The Netflix movie "Sweet Girl," premiering August 20, tackles Big Pharma's pay-for-delay tactic, which withholds cheaper drugs from patients.
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
The deal has clear gains for both sides, but AstraZeneca's shares slid 6% after news of the UK firm's biggest purchase ever.
The FDA has authorized convalescent plasma treatment for coronavirus patients — but some scientists worry it's too soon
The FDA just authorized convalescent plasma as an emergency treatment for COVID-19. It could prevent mild cases from becoming severe.
GOP voters agree with Alexandria Ocasio-Cortez when it comes to one of the thorniest questions in health care
About 65% of Republicans agree the government should play at least some role in influencing prices of drugs like Truvada — an HIV-preventing drug.
8 key takeaways from Trump's State of the Union address
President Trump delivered his second State of the Union address to Congress Tuesday night, focusing on unemployment, immigration, and healthcare.
Advertisement
Advertisement
A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly
Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.
The 17 most and least reputable drug companies in the world
The Reputation Institute took a look at what the general public thought of 17 major pharmaceutical companies. Here's who came out on top.
RANKED: These are the most and least reputable drug companies in the world
The Reputation Institute took a look at what the general public thought of 17 major pharmaceutical companies. Here's who came out on top.
Valeant's collapse — from Clinton's tweet to Ackman's exit
Valeant Pharmaceuticals' stock price has been falling over the past year and a half. Here are the events that punctuated that demise.
A breakthrough approach to treating Alzheimer's is facing major setbacks
Merck has become the latest drugmaker to face a setback to finding drugs to treat Alzheimer's disease.
The FTC is suing 2 drug companies for obstructing generic competition
Allergan and Endo Pharmaceuticals are being sued for obstructing generic drug competition.
Morgan Stanley weighs in on the 9 big questions that will dominate Wall Street in 2017
BI breaks down Morgan Stanley's 2017 edition of Big Debates in which they weigh in on the main debates that will shape the markets in the new year.
Morgan Stanley weighs in on the 9 big questions that will dominate Wall Street in 2017
BI breaks down Morgan Stanley's 2017 edition of Big Debates in which they weigh in on the main debates that will shape the markets in the new year.
Drug spending around the world will hit $1.5 trillion by 2021
The amount of money the world will be spending on drugs will hit $1.5 trillion by 2021, up from roughly $1.2 trillion in 2016, according to a new report.
Drug stocks rip higher after Trump's upset victory signals easing pressure on prices
The win on Prop 61, coupled with a Trump presidency has sent the entire pharmaceutical industry soaring. The NASDAQ biotechnology index was up 8%.
Advertisement
Advertisement
We have the technology to fast-track drug development, but we're not using it yet
According to a new report, there are some areas where big data can be used to benefit patients, but aren't being used to their fullest potential just yet.
Actually, prescription drug coupons can make us spend more on healthcare
A report found that co-pay coupons for branded drugs with generic competition increased drug spending anywhere from $700 million to $2.7 billion.
A biotech company erased $3 billion in value overnight after one of its drugs failed a key trial
Biotech company Alnylam Pharmaceuticals is down almost 50% Thursday after stopping a late-stage clinical trial.
Inside a $5 billion biotech startup that's among the most secretive in the world
A STAT investigation found that Moderna's work environment has driven people away, and there are signs it has run into roadblocks with its projects.
The CEO behind the EpiPen price hikes has a familial tie to the Senate that's put her company in the hot seat
Here's how Mylan CEO Heather Bresch turned Epipen into a billion-dollar product using aggressive advertising — and even more aggressive price hikes.